Clustering of lifestyle behaviours and analysis of their associations with MAFLD: a cross-sectional study of 196,515 individuals in China.

Cluster analysis Lifestyle pattern Lifestyle scoring system MAFLD Multivariate analysis of variance Principal component analysis

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
21 Nov 2023
Historique:
received: 25 10 2022
accepted: 07 11 2023
medline: 27 11 2023
pubmed: 22 11 2023
entrez: 22 11 2023
Statut: epublish

Résumé

The aggregation of lifestyle behaviours and their association with metabolic-associated fatty liver disease (MAFLD) remain unclear. We identified lifestyle patterns and investigated their association with the risk of developing MAFLD in a sample of Chinese adults who underwent annual physical examinations. Annual physical examination data of Chinese adults from January 2016 to December 2020 were used in this study. We created a scoring system for lifestyle items combining a statistical method (multivariate analysis of variance) and clinical expertise (Delphi method). Subsequently, principal component analysis and two-step cluster analysis were implemented to derive the lifestyle patterns of men and women. Binary logistic regression analysis was used to explore the prevalence risk of MAFLD among lifestyle patterns stratified by sex. A total of 196,515 subjects were included in the analysis. Based on the defined lifestyle scoring system, nine and four lifestyle patterns were identified for men and women, respectively, which included "healthy or unhealthy" patterns and mixed patterns containing a combination of healthy and risky lifestyle behaviours. This study showed that subjects with an unhealthy or mixed pattern had a significantly higher risk of developing MAFLD than subjects with a relatively healthy pattern, especially among men. Clusters of unfavourable behaviours are more prominent in men than in women. Lifestyle patterns, as important factors influencing the development of MAFLD, show significant sex differences in the risk of MAFLD. There is a strong need for future research to develop targeted MAFLD interventions based on the identified behavioural clusters by sex stratification.

Sections du résumé

BACKGROUND BACKGROUND
The aggregation of lifestyle behaviours and their association with metabolic-associated fatty liver disease (MAFLD) remain unclear. We identified lifestyle patterns and investigated their association with the risk of developing MAFLD in a sample of Chinese adults who underwent annual physical examinations.
METHODS METHODS
Annual physical examination data of Chinese adults from January 2016 to December 2020 were used in this study. We created a scoring system for lifestyle items combining a statistical method (multivariate analysis of variance) and clinical expertise (Delphi method). Subsequently, principal component analysis and two-step cluster analysis were implemented to derive the lifestyle patterns of men and women. Binary logistic regression analysis was used to explore the prevalence risk of MAFLD among lifestyle patterns stratified by sex.
RESULTS RESULTS
A total of 196,515 subjects were included in the analysis. Based on the defined lifestyle scoring system, nine and four lifestyle patterns were identified for men and women, respectively, which included "healthy or unhealthy" patterns and mixed patterns containing a combination of healthy and risky lifestyle behaviours. This study showed that subjects with an unhealthy or mixed pattern had a significantly higher risk of developing MAFLD than subjects with a relatively healthy pattern, especially among men.
CONCLUSIONS CONCLUSIONS
Clusters of unfavourable behaviours are more prominent in men than in women. Lifestyle patterns, as important factors influencing the development of MAFLD, show significant sex differences in the risk of MAFLD. There is a strong need for future research to develop targeted MAFLD interventions based on the identified behavioural clusters by sex stratification.

Identifiants

pubmed: 37990228
doi: 10.1186/s12889-023-17177-3
pii: 10.1186/s12889-023-17177-3
pmc: PMC10664514
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2303

Subventions

Organisme : Fundamental Research Funds for Central Universities of the Central South University
ID : 2021zzts1016
Organisme : Natural Science Foundation of Hunan Province
ID : 2022JJ70066
Organisme : Key Research and Development Program of Hunan Province of China
ID : 2020SK2089
Organisme : Key Research and Development Program of Hunan Province of China
ID : 2021SK2024
Organisme : National Natural Science Foundation of China
ID : 72074225

Informations de copyright

© 2023. The Author(s).

Références

Int J Environ Res Public Health. 2020 Mar 11;17(6):
pubmed: 32168920
J Clin Med. 2022 Jul 26;11(15):
pubmed: 35893431
J Clin Endocrinol Metab. 2022 Sep 28;107(10):2874-2882
pubmed: 35900115
AJR Am J Roentgenol. 1986 May;146(5):1011-5
pubmed: 3515875
Obes Rev. 2020 Aug;21(8):e13029
pubmed: 32297464
Br J Nutr. 2015 Nov 14;114(9):1464-70
pubmed: 26353803
Trends Genet. 2020 Jun;36(6):429-441
pubmed: 32396836
Nutrients. 2017 Jun 14;9(6):
pubmed: 28613259
Lancet Gastroenterol Hepatol. 2021 Oct;6(10):850-863
pubmed: 34273289
Int J Environ Res Public Health. 2021 Dec 13;18(24):
pubmed: 34948754
Int J Environ Res Public Health. 2019 Jul 04;16(13):
pubmed: 31277386
Biomedicines. 2021 Nov 16;9(11):
pubmed: 34829926
Cancer. 2014 Feb 1;120(3):425-32
pubmed: 24436136
J Clin Endocrinol Metab. 2022 Jan 1;107(1):88-97
pubmed: 34508601
Front Nutr. 2022 Apr 27;9:863834
pubmed: 35571881
Hepatol Int. 2020 Dec;14(6):889-919
pubmed: 33006093
Gastroenterology. 2020 May;158(7):1999-2014.e1
pubmed: 32044314
N Engl J Med. 2020 Oct 1;383(14):1340-1348
pubmed: 32997908
Int J Behav Nutr Phys Act. 2014 Jan 22;11:4
pubmed: 24450617
World J Gastroenterol. 2015 May 14;21(18):5695-706
pubmed: 25987797
Int J Mol Sci. 2016 Jun 02;17(6):
pubmed: 27271596
Fam Med. 2005 May;37(5):360-3
pubmed: 15883903
Biomedicines. 2021 Dec 07;9(12):
pubmed: 34944668
Nutrients. 2015 Dec 28;8(1):
pubmed: 26729155
Nurs Res. 1987 Mar-Apr;36(2):76-81
pubmed: 3644262
Nutr Rev. 2004 May;62(5):177-203
pubmed: 15212319
Nutrients. 2015 Sep 09;7(9):7593-615
pubmed: 26371041
Eur J Nutr. 2020 Aug;59(5):2145-2158
pubmed: 31363827
Pain. 1995 May;61(2):277-284
pubmed: 7659438
Psychol Methods. 2011 Mar;16(1):63-79
pubmed: 21319900
Sports Med. 2018 Feb;48(2):481-489
pubmed: 28647914
Curr Opin Lipidol. 2018 Oct;29(5):404-410
pubmed: 30156571
Curr Obes Rep. 2018 Dec;7(4):276-288
pubmed: 30155850
Hepatol Res. 2021 Nov;51(11):1115-1128
pubmed: 34129272

Auteurs

Bingqian Zhou (B)

Department of Health Management Center, The Third Xiangya Hospital, Central South University, No.138, Tongzipo Road, Changsha, 410013, China.
Xiangya Nursing School, Central South University, Changsha, 410013, China.

Ni Gong (N)

Department of Health Management Center, The Third Xiangya Hospital, Central South University, No.138, Tongzipo Road, Changsha, 410013, China.
Xiangya Nursing School, Central South University, Changsha, 410013, China.

Qingnan He (Q)

Department of Health Management Center, The Third Xiangya Hospital, Central South University, No.138, Tongzipo Road, Changsha, 410013, China.

Xinjuan Huang (X)

Xiangya Nursing School, Central South University, Changsha, 410013, China.

Jingchi Zhu (J)

Jishou University School of Medicine, Jishou, 416000, China.

Lijun Zhang (L)

State Key Laboratory of Ultrasound in Medicine and Engineering, School of Public Health and Management, Chongqing Medical University, No.1, Medical College Road , Chongqing, 400016, China.

Yanyan Huang (Y)

State Key Laboratory of Ultrasound in Medicine and Engineering, School of Public Health and Management, Chongqing Medical University, No.1, Medical College Road , Chongqing, 400016, China.

Xinyun Tan (X)

Xiangya Nursing School, Central South University, Changsha, 410013, China.

Yuanqin Xia (Y)

Jishou University School of Medicine, Jishou, 416000, China.

Yu Zheng (Y)

Xiangya Nursing School, Central South University, Changsha, 410013, China.

Qiuling Shi (Q)

State Key Laboratory of Ultrasound in Medicine and Engineering, School of Public Health and Management, Chongqing Medical University, No.1, Medical College Road , Chongqing, 400016, China. qshi@cqmu.edu.cn.

Chunxiang Qin (C)

Department of Health Management Center, The Third Xiangya Hospital, Central South University, No.138, Tongzipo Road, Changsha, 410013, China. chunxiangqin@csu.edu.cn.
Xiangya Nursing School, Central South University, Changsha, 410013, China. chunxiangqin@csu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH